We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CYTX market cap is 939.43k. The company's latest EPS is USD -2.9441 and P/E is -0.60.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 506k | 1.85M | 1.24M | 1.31M | 1.68M |
| Operating Income | -4.72M | -1.49M | -3.25M | -3.86M | -3.3M |
| Net Income | -4.81M | -1.48M | -3.22M | -3.81M | -3.26M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 7M | 303k | 0 | 224k | 4.91M |
| Operating Income | -3.66M | -9.58M | -12.43M | -19.71M | -13.32M |
| Net Income | -11.44M | -8.24M | -13.4M | -20.28M | -13.32M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 15.64M | 14.2M | 13.28M | 11.39M | 5.62M |
| Total Liabilities | 12.96M | 11.54M | 10.66M | 12.74M | 10.46M |
| Total Equity | 2.68M | 2.66M | 2.62M | -1.35M | -4.84M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 23.23M | 12.11M | 21.98M | 23.87M | 11.39M |
| Total Liabilities | 22.07M | 9.07M | 11.15M | 17.42M | 12.74M |
| Total Equity | 1.16M | 3.03M | 10.84M | 6.45M | -1.35M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.79M | -8.57M | -10.97M | -12.85M | -4.51M |
| Investing | -97k | -108k | -118k | -160k | -364k |
| Financing | 493k | 1.45M | 3.97M | 3.45M | -776k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.91M | -8.43M | -10.28M | -12.97M | -12.85M |
| Investing | 5.57M | -493k | -82k | -759k | -160k |
| Financing | 12.63M | -319k | 20.42M | 13.45M | 3.45M |
| Market Cap | 939.43k |
| Price to Earnings Ratio | -0.60 |
| Price to Sales Ratio | 1.63 |
| Price to Cash Ratio | 0.94 |
| Price to Book Ratio | -5.94 |
| Dividend Yield | - |
| Shares Outstanding | 4.52M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0.48%) |
| Company Name | Cytori Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://plustherapeutics.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
